Get the app
US › Healthcare

Genprex Inc (GNPX)

US · Healthcare · Biotechnology

$2.07-1.43%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-4.4M
EPS
$-9.40

Key statistics

Market cap
$1.7M
Forward P/E
0.0
P/B
0.12
Book value
$29.23
EPS (TTM)
$-9.35
52-week high
$110.00
52-week low
$1.71
50-day MA
$2.83
200-day MA
$19.16
Beta
-0.99

Analyst view

with an average price target of $7.50.

Shareholding

Insiders
0.21%
Institutions
1.73%

Largest institutional holders

FundStake
Vanguard Fiduciary Trust Co0.43%
HRT FINANCIAL LLC0.40%
Geode Capital Management, LLC0.33%
Vanguard Capital Management, LLC0.20%
Mayflower Financial Advisors, LLC0.11%
UBS Group AG0.02%
Cheviot Value Management, Inc.0.01%
BlackRock Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Genprex Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.